PET, fMRI find psychopaths have higher dopamine levels

Article

High dopamine levels are linked to a greater level of such psychopathic traits as manipulativeness, egocentricity, aggression, and risk-taking, a study by Vanderbilt University researchers has found.

High dopamine levels are linked to a greater level of such psychopathic traits as manipulativeness, egocentricity, aggression, and risk-taking, a study by Vanderbilt University researchers has found.

Using PET and fMRI studies, the researchers looked for changes in the dopamine reward circuitry. They also had all participants complete a personality inventory to assess their tendencies to psychopathic behavior.

After volunteers were given a dose of amphetamine, they were scanned with PET to measure dopamine release. Substance abuse has been shown in the past to be associated with alterations in dopamine responses; the researchers hypothesized that psychopathic traits were also linked to dysfunction in dopamine reward circuitry.

“Consistent with what we thought, we found people with high levels of psychopathic traits had almost four times the amount of dopamine released in response to amphetamine,” said Joshua Buckholtz, a graduate student in psychology and lead author of the study.

In the fMRI portion of the test, volunteers were scanned while told they would receive a monetary reward for completing a simple task. The dopamine reward area was more active in subjects with elevated psychopathic traits than in other volunteers while subjects anticipated the monetary reward.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.